STRS Ohio’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
STRS Ohio's SCTX Position: Q3 2026 in Review
STRS Ohio opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 2,600 shares worth $47.9K. The stake represents ﹤0.01% of the portfolio and ranks #2057 among its holdings.
63 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- STRS Ohio held 2,600 shares of Scribe Therapeutics worth $47.9K as of Q3 2026.
- Scribe Therapeutics was a new STRS Ohio position in Q3 2026.
- Scribe Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2057 holding.
- 63 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.